M. Lassen

发表

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.

M. Gent, B. Eriksson, A. Turpie, 2012, The Journal of bone and joint surgery. British volume.

Periprocedural Management of Antithrombotic Therapy and Use of Bridging Anticoagulation

G. Raskob, A. Nicolaides, M. Griffin, 2008, International Angiology.

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

B. Eriksson, A. Turpie, K. Bauer, 2002, Archives of internal medicine.

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients

D Bergqvist, B Eriksson, B. Eriksson, 2010, Journal of thrombosis and haemostasis : JTH.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.

W. Ageno, A. Turpie, J. Lieberman, 2008, The New England journal of medicine.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

M. Gent, A. Turpie, K. Bauer, 2009, The Lancet.

Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

G. Raskob, R. Portman, G. Pineo, 2009, The New England journal of medicine.

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

G. Raskob, G. Pineo, Dalei Chen, 2010, The Lancet.

Inflammatory and Procoagulant Cytokine Levels During Pregnancy as Predictors of Adverse Obstetrical Complications

J. Cunanan, D. Hoppensteadt, J. Fareed, 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran.

B. Eriksson, G. Agnelli, D. Bergqvist, 2009, Thrombosis research.

Emergence of new oral antithrombotics: a critical appraisal of their clinical potential

V. Laux, M. Lassen, 2008, Vascular health and risk management.

Phlebography as the Gold Standard in Thromboprophylactic Studies?

L. Jørgensen, P. Wille-Jørgensen, L. Borris, 1992 .

Heparin-Induced Thrombocytopenia

G. Raskob, A. Nicolaides, M. Griffin, 2013, Thrombosis and Haemostasis.

Treatment for Patients With Cancer

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Diagnosis and Anticoagulant Treatment *

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Key Questions to be Answered

G. Raskob, A. Nicolaides, M. Griffin, 2013 .

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions

L. Mantovani, A. Turpie, R. Kreutz, 2016, British journal of clinical pharmacology.

Prevention of venous thromboembolism.

C. Colwell, J. Heit, W. Geerts, 1994, Chest.

Rivaroxaban for Thromboprophylaxis After Nonelective Orthopedic Trauma Surgery in Switzerland.

H. Simmen, C. Sommer, P. Hoffmeyer, 2017, Orthopedics.

Inferior Vena Cava Filters

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

M. Prins, A. Turpie, A. Cohen, 2006, BMJ : British Medical Journal.

Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.

B. Eriksson, A. Turpie, K. Bauer, 2004, Chest.

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.

B. Eriksson, M. Lassen, 2003, Archives of internal medicine.

Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty

M. Gent, B. Eriksson, A. Turpie, 2010, Thrombosis and Haemostasis.

Definition of major bleeding in surgery: an anesthesiologist’s point of view: reply to a rebuttal

B. Eriksson, D. Bergqvist, S. Schulman, 2010 .

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

L. Mantovani, A. Turpie, R. Kreutz, 2012, Vascular health and risk management.

Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study

D. Ward, R. Rothlein, B. Eriksson, 2008, Journal of thrombosis and haemostasis : JTH.

Investigations of the immunoglobulin subtype transformation of anti-heparin-platelet factor 4 antibodies during treatment with a low-molecular-weight heparin (clivarin) in orthopedic patients.

D. Hoppensteadt, J. Fareed, Sarfraz Ahmad, 2003, Archives of pathology & laboratory medicine.

Fondaparinux, the first selective factor Xa inhibitor

B. Eriksson, A. Turpie, K. Bauer, 2003, Current opinion in hematology.

Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 study.

A. Turpie, D. George, G. Agnelli, 2013, The bone & joint journal.

Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization.

L. Borris, M. Lassen, R. Nakov, 2002, The New England journal of medicine.

Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism

B. Eriksson, A. Turpie, K. Bauer, 2002, Current opinion in pulmonary medicine.

The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery – subgroup analyses from 17,701 patients in the XAMOS study

L. Mantovani, A. Turpie, R. Kreutz, 2016, Vascular health and risk management.

A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery

M. Prins, B. Eriksson, A. Turpie, 2007, Journal of thrombosis and haemostasis : JTH.

The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement 1

G. Pineo, J. Ansell, A. Gallus, 2007, Journal of thrombosis and haemostasis : JTH.

YM150, an Oral Direct Factor Xa Inhibitor, as Prophylaxis for Venous Thromboembolism in Patients with Elective Primary Hip Replacement Surgery. A Dose Escalation Study.

M. Prins, B. Eriksson, A. Turpie, 2005 .

Superficial Vein Thrombosis

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Once-Daily Oral Rivaroxaban Compared with Subcutaneous Enoxaparin Every 12 Hours for Thromboprophylaxis after Total Knee Replacement: RECORD4

M. Gent, A. Turpie, K. Bauer, 2008 .

The Problem and the Need for Prevention

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX‐2)

M. Prins, B. Eriksson, A. Turpie, 2010, Journal of thrombosis and haemostasis : JTH.

Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery: A Randomized Controlled Trial

A. Turpie, D. George, G. Agnelli, 2014, Annals of surgery.

The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery

A. Turpie, D. George, G. Agnelli, 2010 .

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.

M. Gent, B. Eriksson, A. Turpie, 2009, The Journal of bone and joint surgery. British volume.

AVE5026, a new hemisynthetic ultra‐low‐molecular‐weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose‐ranging study

A. Turpie, P. Mismetti, M. Lassen, 2009, Journal of thrombosis and haemostasis : JTH.

SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) study.

P. Mismetti, A. Turpie, M. Lassen, 2008, Journal of the American College of Cardiology.

New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.

B. Eriksson, A. Turpie, K. Bauer, 2003, Chest.

Gynecology and Obstetrics

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use.

C. Colwell, S. Frostick, B. Eriksson, 2008, International angiology : a journal of the International Union of Angiology.

Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.

G. Raskob, G. Pineo, A. Gallus, 2012, The Journal of bone and joint surgery. British volume.

Prevention of Postthrombotic Syndrome

G. Raskob, A. Nicolaides, M. Griffin, 2013 .

Recent developments in the use of oral anticoagulants

M. Lassen, 2009, Expert opinion on pharmacotherapy.

Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery

B. Eriksson, A. Turpie, K. Bauer, 2003, The Lancet.

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.

G. Raskob, S. Berkowitz, J. Weitz, 2020, JAMA.

Sustained Release of Tissue Factor Following Thrombosis of Lower Limb Trauma

D. Hoppensteadt, J. Fareed, W. Jeske, 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.

B. Eriksson, A. Turpie, K. Bauer, 2002, Journal of the Southern Orthopaedic Association.

Fondaparinux.

B. Eriksson, A. Turpie, K. Bauer, 2020, The Journal of the American Academy of Orthopaedic Surgeons.

Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding events

M. Breindahl, L. Borris, Á. Pap, 2008, Journal of thrombosis and haemostasis : JTH.

Fondaparinux versus enoxaparin for prevention of venous thromboembolism

A. Turpie, M. Lassen, 2002, The Lancet.

Venous Thromboembolism (VTE) Prevention with Semuloparin in Cancer Patients Initiating Chemotherapy: Benefit-Risk Assessment by VTE Risk in SAVE-ONCO

A. Turpie, D. George, G. Agnelli, 2011 .

Do editors live up to the Sept 10, 2001, expectations?

A. Turpie, KA Bauer, M. Lassen, 2002, The Lancet.

ORIGINAL ARTICLE: Soluble Human Leukocyte Antigen‐G Isoforms in Maternal Plasma in Early and Late Pregnancy

R. Rizzo, M. Stignani, L. Melchiorri, 2009, American journal of reproductive immunology.

Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups

G. Raskob, G. Pineo, Dalei Chen, 2013, Journal of Thrombosis and Haemostasis.

Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE

A. Kakkar, A. Turpie, D. George, 2012, Journal of thrombosis and haemostasis : JTH.

Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice

L. Mantovani, A. Turpie, R. Kreutz, 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Is the preoperative administration of enoxaparin 40 mg necessary to optimally prevent the occurrence of venous thromboembolism after hip surgery? A subanalysis of two pooled randomized trials

M. Lassen, 2009, Journal of thrombosis and haemostasis : JTH.

Influence of the duration of fondaparinux (Arixtra®) prophylaxis in preventing venous thromboembolism following major orthopedic surgery

B. Eriksson, A. Turpie, K. Bauer, 2003, Journal of thrombosis and haemostasis : JTH.

3001 POSTER DISCUSSION Ultra-low-molecular-weight Heparin (ULMWH) Semuloparin for Prevention of Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: Consistent Beneficial Effect Across Cancer Stage and Location Subgroups

A. Turpie, D. George, G. Agnelli, 2011 .

The ultra-low molecular weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) in patients with cancer receiving chemotherapy: SAVE ONCO study.

A. Turpie, D. George, G. Agnelli, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients.

C. Colwell, B. Eriksson, M. Lassen, 2004, The Journal of arthroplasty.

Critical Care Medical Patients

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis.

A Phase II Randomized, Double-Blind, Eight-Arm, Parallel-Group, Dose-Response Study of Apixaban, a New Oral Factor Xa Inhibitor for the Prevention of Deep Vein Thrombosis in Knee Replacement Surgery - On Behalf of the Apixaban Investigators.

G. Pineo, J. Ansell, A. Gallus, 2006 .

Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty.

M. Breindahl, L. Borris, M. Lassen, 2007, Thrombosis research.

Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review

M. Gent, B. Eriksson, A. Turpie, 2004, Journal of thrombosis and haemostasis : JTH.

Phlebography as the Gold Standard in Thromboprophylactic Studies?

L. Jørgensen, P. Wille-Jørgensen, L. Borris, 1992, Acta radiologica.

Fondaparinux Reduces Long-term Risk of Venous Thromboembolism After Surgery for Hip Fractur

C. Colwell, B. Eriksson, A. Turpie, 2003 .

Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration

B. Eriksson, A. Turpie, K. Bauer, 2003, Thrombosis and Haemostasis.

COMPARISON OF RIVAROXABAN – AN ORAL, DIRECT FACTOR XA INHIBITOR–AND SUBCUTANEOUS ENOXAPARIN FOR THROMBOPROPHYLAXIS AFTER TOTAL KNEE REPLACEMENT (RECORD4: A PHASE III STUDY)

M. Gent, A. Turpie, K. Bauer, 2010 .

Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects.

M. Levi, F. Haverkate, M. D. de Maat, 1999, The Journal of laboratory and clinical medicine.

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison

Bengt I Eriksson, B. Eriksson, A. Turpie, 2002, The Lancet.

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial

Bengt I Eriksson, B. Eriksson, A. Turpie, 2002, The Lancet.

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

B. Eriksson, A. Turpie, K. Bauer, 2001, The New England journal of medicine.

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.

B. Eriksson, A. Turpie, K. Bauer, 2001, The New England journal of medicine.

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Clifford W Colwell, C. Colwell, J. Heit, 2004, Chest.

Prevention of Venous Thromboembolism* American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition)

Clifford W Colwell, C. Colwell, C. Samama, 2008 .

A Pilot Study of the Effects of Vivostat Patient-derived Fibrin Sealant in Reducing Blood Loss in Primary Hip Arthroplasty

M. Lassen, S. Solgaard, A. Kjersgaard, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Inflammatory Biomarker Profiling in Elderly Patients With Acute Hip Fracture Treated With Heparins

D. Hoppensteadt, J. Fareed, C. Adiguzel, 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Patients With Cancer

S. Kakkos, P. Prandoni, G. Raskob, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prevention and Treatment of Venous Thromboembolism

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Dose Relation in the Prevention of Proximal Vein Thrombosis with a Low Molecular Weight Heparin (Tinzaparin) in Elective Hip Arthroplasty

P. Ejstrud, L. Borris, M. Lassen, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Modic Changes are not Associated with Long-Term Pain and Disability - A Cohort Study With 13-Year Follow-up.

S. Brorson, T. Bendix, L. Carreon, 2019, Spine.

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.

G. Raskob, G. Pineo, Dalei Chen, 2010, The New England journal of medicine.

Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)

M. Prins, B. Eriksson, A. Turpie, 2013, Thrombosis and Haemostasis.

Milvexian for the Prevention of Venous Thromboembolism.

G. Raskob, W. Ageno, K. Mahaffey, 2021, The New England journal of medicine.

Psychometric Validation of the Danish Version of the Oswestry Disability Index in Patients with Chronic Low Back Pain.

N. Wedderkopp, J. Brodersen, J. Comins, 2020, Spine.

Orthopedic Surgery and Trauma

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Lectin pathway proteins of the complement system in normotensive pregnancy and pre‐eclampsia

S. Thiel, A. Hvas, M. Lassen, 2019, American journal of reproductive immunology.

General, Vascular, Bariatric, and Plastic Surgical Patients

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis.

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

B. Eriksson, A. Cohen, G. Agnelli, 2003, Journal of thrombosis and haemostasis : JTH.

Prevention and treatment of venous thromboembolism--International Consensus Statement.

P Prandoni, G D Lowe, D Bergqvist, 2013, International angiology : a journal of the International Union of Angiology.

Comparison of Real-Time B-Mode Ultrasonog raphy and Bilateral Ascending Phlebography for Detection of Postoperative Deep Vein Thrombosis Following Elective Hip Surgery

L. Borris, M. Lassen, A. Olsen, 1989, Thrombosis and Haemostasis.

A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment

L. Mantovani, A. Turpie, R. Kreutz, 2013, Thrombosis and Haemostasis.

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

A. Turpie, D. George, G. Agnelli, 2012, The New England journal of medicine.

A Pooled Analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effect on Symptomatic Venous Thromboembolism, Death, and Bleeding

M. Gent, B. Eriksson, A. Turpie, 2008 .

Once Daily YM150, an Oral Direct Factor Xa Inhibitor, for Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Hip Replacement.

M. Prins, B. Eriksson, A. Turpie, 2007 .

Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification.

I. Seljeflot, A. Pripp, L. Borris, 2013, Thrombosis research.

Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism.

I. Seljeflot, Trine Lauritzen, A. Pripp, 2014, Thrombosis research.

Urinary Prothrombin Fragment 1+2 in relation to Development of Non-Symptomatic and Symptomatic Venous Thromboembolic Events following Total Knee Replacement

M. Breindahl, L. Borris, Á. Pap, 2011, Thrombosis.

Urologic Surgery

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Cost-Effectiveness of Prevention and Treatment of VTE

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

O1067 INFLUENCE OF THE DURATION OF FONDAPARINUX PROPHYLAXIS IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING HIP FRACTURE SURGERY

B. Eriksson, A. Turpie, K. Bauer, 2004 .

Thromboprophylaxis with Low Molecular Weight Heparin after Major Orthopaedic Surgery is Cost Effective

L. Borris, M. Lassen, 2012, Drugs.

Prophylaxis for the thromboembolic disease--recommendations from the American College of Chest Physicians--are they appropriate for orthopaedic surgery?

C. Colwell, J. Heit, W. Geerts, 2006, The Journal of arthroplasty.

Rivaroxaban - An Oral, Direct Factor Xa Inhibitor - for Thromboprophylaxis after Total Knee Arthoplasty: The RECORD3 Trial.

W. Ageno, A. Turpie, J. Lieberman, 2007 .

Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.

B. Eriksson, R. Friedman, M. Lassen, 2008, Clinical orthopaedics and related research.

Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.

B. Eriksson, R. Friedman, M. Lassen, 2008, Clinical orthopaedics and related research.

Prevention of venous thromboembolism.

C. Colwell, J. Heit, F. Anderson, 1994, Chest.

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.

C. Howie, M. Gent, P. Gaston, 2010, The Journal of bone and joint surgery. British volume.

Potential influence of observer variation in thromboprophylactic trials.

L. Jørgensen, P. Wille-Jørgensen, L. Borris, 1992, Haemostasis.

Thrombophilia

G. Raskob, S. Goldhaber, A. Turpie, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Combined Modalities in Surgical Patients

G. Raskob, A. Nicolaides, M. Griffin, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo.

S. Eiskjær, J. Rodenberg, L. Borris, 1991, Acta orthopaedica Scandinavica.

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

C. Colwell, C. Samama, J. Heit, 2008, Chest.

Medical Patients

G. Geroulakos, A. Turpie, K. Myers, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

C. Colwell, C. Samama, J. Heit, 2008, Chest.

Prevention and Treatment of Venous Thromboembolism

G. Geroulakos, K. Myers, J. Conard, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

C. Colwell, J. Heit, W. Geerts, 2004, Chest.

Letter to the Editor

B. Eriksson, R. Friedman, M. Lassen, 2008, Clinical Orthopaedics and Related Research.

Thrombolytic Therapy

G. Geroulakos, K. Myers, J. Conard, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prevention and treatment of venous thromboembolism

G. Raskob, A. Nicolaides, M. Griffin, 1990 .